Brian A. Belt

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinoma”.

Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinoma

Immunological Investigations(2020)10.1080/08820139.2020.1765795

N/A

0DataRank · unranked

13 citations

Joseph D. Murphy, Shuyang Qin, Jian Ye, Taylor P. Uccello, Jesse Garrett-Larsen +8 more

Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body Radiotherapy

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2495

N/A

0DataRank · unranked

69 citations

Haoming Qiu, Michael G. Drage, Chunmo Chen, Jocelyn S. Mathew, Jesse Garrett-Larsen +9 more

A phase I study to evaluate the safety and tolerability of SX-682 in combination with PD-1 inhibitor as maintenance therapy for unresectable pancreatic adenocarcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps631

N/A

0DataRank · unranked

10 citations

Nicholas A. Ullman, Brian A. Belt, Luis I. Ruffolo, Paul R. Burchard, Aram F. Hezel +7 more

CD73 and PD-L1 dual blockade amplifies antitumor efficacy of SBRT in murine PDAC models

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-006842

N/A

0DataRank · unranked

29 citations

Nicholas W Gavras, David C Keeley, Angela Hughson, Gary Hannon, Tara G Vrooman +8 more

Data from Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body Radiotherapy

(2023)10.1158/1078-0432.c.6531156.v1

N/A

0DataRank · unranked

0 citations

Haoming Qiu, Michael G. Drage, Chunmo Chen, Jocelyn S. Mathew, Jesse Garrett-Larsen +9 more

Phase 1b/2 trial of pepinemab plus avelumab as second line combination immunotherapy for patients with metastatic pancreatic adenocarcinoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4195

N/A

0DataRank · unranked

0 citations

Terrence L. Fisher, Elizabeth E. Evans, Crystal Mallow, Megan Boise, Amber Foster +7 more

Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC Models

Cancers(2025)10.3390/cancers17020204

N/A

0DataRank · unranked

4 citations

Shuyang Qin, Angela Hughson, Gary Hannon, Tara G Vrooman, Maggie L. Lesch +10 more

Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Adenocarcinoma

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.06.3853

N/A

0DataRank · unranked

0 citations

Gary Hannon, Bradley N. Mills, Angela Hughson, Taylor P. Uccello, Nicholas W Gavras +10 more